Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (721-730 of 4,681) with videos related to

Pageof 469
Sort By:
Cancer Discovery|December 15, 2022
Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal CancerAndreana N Holowatyj, Wanqing Wen, Timothy Gibbs, et al.
Cancer Discovery|December 16, 2022
Adavosertib Is Safe and Efficacious in CCNE1-Amplified Solid Tumors
Cancer Discovery|December 16, 2022
BTK Inhibitor Options Expand for CLL/SLL
Cancer Discovery|December 9, 2022
Myeloid-Derived Itaconate Suppresses Antitumor Immunity
Cancer Discovery|December 9, 2022
T-DXd Keeps Shining in Breast Cancer
Cancer Discovery|December 12, 2022
Capivasertib Doubles PFS in Some Breast Cancers
Cancer Discovery|June 9, 2022
Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in MiceJulia L Drewes, Jie Chen, Nicholas O Markham, et al.
Cancer Discovery|May 29, 2021
Transcriptome Analysis Predicts Treatment Response
Cancer Discovery|July 3, 2021
Inhibition of RNA Splicing Drives Tumor Neoepitope Production
Cancer Discovery|July 3, 2021
<i>HER3</i> Mutations Affect Tumor Response to HER2-Targeted Therapies
Pageof 469

Showing results (721-730 of 4,681) with videos related to

Sort By:
Pageof 469
Cancer Discovery|December 15, 2022
Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal CancerAndreana N Holowatyj, Wanqing Wen, Timothy Gibbs, et al.
Cancer Discovery|December 16, 2022
Adavosertib Is Safe and Efficacious in CCNE1-Amplified Solid Tumors
Cancer Discovery|December 16, 2022
BTK Inhibitor Options Expand for CLL/SLL
Cancer Discovery|December 9, 2022
Myeloid-Derived Itaconate Suppresses Antitumor Immunity
Cancer Discovery|December 9, 2022
T-DXd Keeps Shining in Breast Cancer
Cancer Discovery|December 12, 2022
Capivasertib Doubles PFS in Some Breast Cancers
Cancer Discovery|June 9, 2022
Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in MiceJulia L Drewes, Jie Chen, Nicholas O Markham, et al.
Cancer Discovery|May 29, 2021
Transcriptome Analysis Predicts Treatment Response
Cancer Discovery|July 3, 2021
Inhibition of RNA Splicing Drives Tumor Neoepitope Production
Cancer Discovery|July 3, 2021
<i>HER3</i> Mutations Affect Tumor Response to HER2-Targeted Therapies
Pageof 469